Merck MRK Cash Flow Statement (2009-2026)

NYSE MRK
$147.53 -0.93 (-0.63%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Merck Quarterly Cash Flow Statement

Periods 70 quarters
Latest Jun 2026

Merck reported cash from operations of $5.37B and free cash flow of $4.48B for the quarter ended Jun 2026, up 63.1% year over year. This cash flow statement covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
4.57B3.76B4.31B3.95B3.25B3.02B2.83B-5.97B4.75B-1.23B4.77B5.46B3.16B3.74B5.08B4.43B5.79B2.96B-4.24B-1.34B
Share-based CompensationStock Comp.
0.12B0.12B0.12B0.14B0.14B0.14B0.14B0.17B0.16B0.17B0.18B0.20B0.20B0.19B0.20B0.22B0.20B0.20B0.18B0.30B
Deferred Taxes
-0.00B0.16B-0.34B-0.26B-0.66B-0.31B-0.28B-0.35B-0.34B-0.93B-0.05B-0.18B-0.40B-0.62B-0.19B-0.45B-0.21B-0.82B-0.32B-0.54B
Cash from Discontinued OperationsCash from Discont. Ops
-0.06B
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
0.30B0.89B0.84B0.78B
Cash from OperationsCash from Ops.
4.80B5.09B4.76B4.30B5.60B4.43B1.34B3.70B7.72B0.25B3.09B5.64B9.29B3.45B2.50B3.29B7.82B2.86B3.92B5.37B
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.36B0.41B0.70B0.46B0.46B0.46B0.54B0.48B0.56B0.46B0.47B0.61B0.63B0.68B0.60B0.60B0.62B0.97B0.93B0.98B
Depreciation & Amortization (CF)Dep. & Amort.
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
Change in Account PayablesChange Payables
Change in Accured ExpensesChange Accured Exp.
Other Working Capital ChangesOther WC Changes
0.14B-2.04B1.30B1.40B-0.26B-0.96B2.89B1.64B-2.18B-0.04B3.38B1.01B-2.58B-0.40B3.71B2.26B-1.31B-1.35B1.61B-0.42B
Investing Activities
Capital ExpendituresCapex
1.17B1.21B0.98B1.13B1.13B1.15B1.01B0.96B0.90B0.99B0.86B0.79B0.78B0.94B1.33B0.76B0.99B1.03B0.99B0.89B
Sales of Property, Plant and EquipmentPP&E (Sale)
Acquisitions
-0.00B0.09B0.12B-0.12B0.75B0.60B-1.34B10.04B8.78B
Divestments
Change in Acquisitions & DivestmentsChange Acquisitions
0.11B0.53B0.00B0.37B0.34B0.01B0.50B0.28B0.70B0.17B0.26B0.06B0.05B0.01B0.46B0.60B0.57B0.05B1.30B
Cash from Investing ActivitiesCash from Investing
-1.06B-12.05B-1.17B-1.08B-0.96B-1.75B-2.36B-11.44B-0.33B0.05B-1.38B-1.07B-3.85B-1.44B-1.49B-0.77B-0.28B-11.20B-10.21B-5.60B
Financing Activities
Other financing activitiesOther financing
-0.10B-0.10B0.04B0.56B-0.08B-0.23B-0.01B-0.00B0.09B-0.39B-0.03B-0.04B-0.06B-0.15B-0.05B0.12B0.16B-0.51B
Cash from Financing ActivitiesCash from Financing
-2.27B5.21B-3.09B-1.78B-2.70B-1.55B-2.05B3.76B-4.27B-2.25B-2.81B1.22B-2.42B-3.01B-5.75B-3.56B2.64B4.75B-2.98B1.76B
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
1.65B1.64B1.75B1.77B1.75B1.75B1.85B1.89B1.85B1.85B1.95B1.99B1.95B1.95B2.05B2.08B2.03B2.02B2.10B2.14B
Additional items
Exchange Rate EffectFX Effect
-0.05B-0.07B-0.06B-0.31B-0.41B0.37B0.09B-0.09B-0.16B0.19B-0.14B-0.08B0.29B-0.37B0.16B0.37B0.01B0.02B-0.02B-0.04B
Change in Cash
1.42B-1.88B0.45B1.14B1.53B1.49B-2.99B-4.07B2.96B-1.76B-1.24B5.70B3.31B-1.37B-4.59B-0.66B10.19B-3.57B-9.29B1.49B
Free Cash FlowFCF
3.62B3.89B3.78B3.17B4.48B3.28B0.33B2.74B6.82B-0.74B2.23B4.85B8.51B2.51B1.17B2.53B6.83B1.82B2.93B4.48B
Net Cash FlowNCF
1.46B-1.75B0.50B1.45B1.94B1.13B-3.07B-3.98B3.11B-1.95B-1.10B5.78B3.02B-1.00B-4.74B-1.03B10.18B-3.59B-9.27B1.53B